iTeos Therapeutics Inc.

6.32
-0.38 (-5.74%)
At close: Mar 28, 2025, 3:59 PM
6.48
2.53%
After-hours: Mar 28, 2025, 05:14 PM EDT

iTeos Therapeutics Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18
Revenue 35M 12.6M 267.63M 344.77M n/a n/a n/a
Cost of Revenue n/a 898K 813K 615K 535K 611K 505K
Gross Profit 35M 11.7M 266.82M 344.16M -535K -611K -505K
Operating Income -159.53M -151.1M 126.32M 244.9M -45.24M -28.05M -21.5M
Interest Income 30.87M 31.77M 11.36M 78K n/a n/a n/a
Pretax Income -120.34M -109.03M 148.74M 256.46M -38.09M -22.34M -18.05M
Net Income -134.41M -112.64M 96.65M 214.52M -38.03M -22.45M -18.06M
Selling & General & Admin 49.08M 50.4M 43.95M 40.51M 15.34M 8.84M 4.31M
Research & Development 145.45M 113.3M 97.36M 59.37M 29.9M 19.21M 17.19M
Other Expenses n/a n/a -3.26M -10.18M -5.93M -4.78M -163K
Operating Expenses 194.53M 163.7M 138.04M 89.69M 39.31M 23.27M 17.82M
Interest Expense n/a n/a n/a n/a n/a n/a 66K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 194.53M 163.7M 138.04M 89.69M 39.31M 23.27M 17.82M
Income Tax 14.07M 3.61M 52.08M 41.94M -57K 119K 11K
Shares Outstanding (Basic) 40.47M 35.76M 35.55M 35.18M 35.04M 35.02M 7.51M
Shares Outstanding (Diluted) 40.47M 35.76M 37.77M 37.77M 35.04M 35.02M 7.51M
EPS (Basic) -3.32 -3.15 2.72 6.10 -1.09 -0.64 -2.4
EPS (Diluted) -3.32 -3.15 2.56 5.68 -1.09 -0.64 -2.4
EBITDA -153.09M -151.1M 148.38M 257.08M -37.84M -21.72M -17.48M
Depreciation & Amortization 1.24M 898K 813K 615K 535K 611K 505K